Pay in 4 interest-free payments of $7.47 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
In 2006, the research-and-development arm of Pliva was acquired by GlaxoSmithKline, which has ample resources for clinical trials, but the company has not commercialized the peptide
PMID 14500546
34 34 Preprint at (2022)
The results often last up to 12 months
Peptide treatments typically require ongoing use to maintain benefits
The most-studied are Epitalon (telomeres), MOTS-c and Humanin (mitochondrial-derived peptides), SS-31 (mitochondrial protection), plus NAD+ and glutathione, which are non-peptide molecules studied alongside them for cellular energy and antioxidant balance
US$ 20.61
US$ 25.66
US$ 28.33
US$ 26.31
US$ 20.88
